Stay updated on FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.

Latest updates to the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe site footer revision changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe FT-2102 Phase 1b/2 clinical trial record is now displayed instead of an error page, with details on the study design, participant criteria, treatment arms, results measures, and participating locations. The record also includes publication and study documents.SummaryDifference79%

- Check21 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide banner announces NIH website updates and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe study record page is showing a 403 Forbidden error, with a Home button, instead of its previous content.SummaryDifference0.6%

Stay in the know with updates to FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.